Cytek Biosciences (CTKB) Inventory Average (2021 - 2026)

Cytek Biosciences' Inventory Average history runs 6 years deep, the most recent figure standing at $49.1 million for Q1 2026.

• Quarterly Inventory Average rose 10.06% year-over-year to $49.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.1 million (up 10.06% YoY) and the FY2025 annual result came in at $46.2 million, down 11.88% from the prior year.
• Inventory Average was $49.1 million for Q1 2026 at Cytek Biosciences, down from $50.0 million in the prior quarter.
• Across five years, Inventory Average topped out at $67.6 million in Q2 2023 and bottomed at $35.1 million in Q1 2022.
• A 5-year average of $51.5 million and a median of $49.1 million in 2026 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2022 — Inventory Average jumped 74.86% — and 2024, when it declined 29.01%.
• Cytek Biosciences' Inventory Average stood at $48.8 million in 2022, then soared by 31.0% to $63.9 million in 2023, then retreated by 29.01% to $45.3 million in 2024, then climbed by 10.35% to $50.0 million in 2025, then retreated by 1.86% to $49.1 million in 2026.
• Business Quant data shows CTKB's Inventory Average at $49.1 million in Q1 2026, $50.0 million in Q4 2025, and $50.6 million in Q3 2025.